Literature DB >> 20404090

Genetic analysis of cytoprotective functions supported by graded expression of Keap1.

Keiko Taguchi1, Jonathan M Maher, Takafumi Suzuki, Yukie Kawatani, Hozumi Motohashi, Masayuki Yamamoto.   

Abstract

Keap1 regulates Nrf2 activity in response to xenobiotic and oxidative stresses. Nrf2 is an essential regulator of cytoprotective genes. Keap1-null mice are lethal by weaning age due to malnutrition caused by severe hyperkeratosis of the upper digestive tract. Analysis of Keap1::Nrf2 double mutant mice revealed that currently recognizable phenotypes of Keap1-null mice are all attributable to constitutive activation of Nrf2. We previously reported that hepatocyte-specific Keap1 knockout (Keap1(flox/-)::Albumin-Cre) mice are viable and more resistant to acute toxicity of acetaminophen (APAP). In the current study, we found that the floxed Keap1 allele is hypomorphic and that Keap1 expression was decreased in all examined tissues of Keap1(flox/-) mice. Taking advantage of the hypomorphic phenotype of Keap1(flox/-) mice, we examined the effects of graded reduction of Keap1 expression in adult mice. When challenged with APAP, Keap1(flox/-) mice were more protected from mortality than wild-type and even Keap1(flox/-)::Albumin-Cre mice. In contrast, a decrease in Keap1 levels to less than 50% resulted in increased mortality in a study of 2-year-old mice. These results support our contention that the benefits of Nrf2 activation in acute toxicity are hormetic and that constitutive Nrf2 activation beyond a certain threshold is rather disadvantageous to long-term survival.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404090      PMCID: PMC2876677          DOI: 10.1128/MCB.01591-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development.

Authors:  M Tarutani; S Itami; M Okabe; M Ikawa; T Tezuka; K Yoshikawa; T Kinoshita; J Takeda
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice.

Authors:  C Byrne; E Fuchs
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

3.  The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1.

Authors:  Masaaki Komatsu; Hirofumi Kurokawa; Satoshi Waguri; Keiko Taguchi; Akira Kobayashi; Yoshinobu Ichimura; Yu-Shin Sou; Izumi Ueno; Ayako Sakamoto; Kit I Tong; Mihee Kim; Yasumasa Nishito; Shun-ichiro Iemura; Tohru Natsume; Takashi Ueno; Eiki Kominami; Hozumi Motohashi; Keiji Tanaka; Masayuki Yamamoto
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

4.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

Authors:  K Itoh; T Chiba; S Takahashi; T Ishii; K Igarashi; Y Katoh; T Oyake; N Hayashi; K Satoh; I Hatayama; M Yamamoto; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  1997-07-18       Impact factor: 3.575

5.  NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development.

Authors:  K Chan; R Lu; J C Chang; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

Review 6.  Nrf2-Keap1 defines a physiologically important stress response mechanism.

Authors:  Hozumi Motohashi; Masayuki Yamamoto
Journal:  Trends Mol Med       Date:  2004-11       Impact factor: 11.951

7.  Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation.

Authors:  Nobunao Wakabayashi; Ken Itoh; Junko Wakabayashi; Hozumi Motohashi; Shuhei Noda; Satoru Takahashi; Sumihisa Imakado; Tomoe Kotsuji; Fujio Otsuka; Dennis R Roop; Takanori Harada; James Douglas Engel; Masayuki Yamamoto
Journal:  Nat Genet       Date:  2003-09-28       Impact factor: 38.330

8.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain.

Authors:  K Itoh; N Wakabayashi; Y Katoh; T Ishii; K Igarashi; J D Engel; M Yamamoto
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

9.  Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.

Authors:  Akira Kobayashi; Moon-Il Kang; Hiromi Okawa; Makiko Ohtsuji; Yukari Zenke; Tomoki Chiba; Kazuhiko Igarashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival.

Authors:  Mi-Kyoung Kwak; Nobunao Wakabayashi; Ken Itoh; Hozumi Motohashi; Masayuki Yamamoto; Thomas W Kensler
Journal:  J Biol Chem       Date:  2002-12-27       Impact factor: 5.157

View more
  80 in total

1.  IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model.

Authors:  H Kitamura; Y Onodera; S Murakami; T Suzuki; H Motohashi
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

2.  Nrf2 enhances cholangiocyte expansion in Pten-deficient livers.

Authors:  Keiko Taguchi; Ikuo Hirano; Tohru Itoh; Minoru Tanaka; Atsushi Miyajima; Akira Suzuki; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2013-12-30       Impact factor: 4.272

3.  Notch-Nrf2 axis: regulation of Nrf2 gene expression and cytoprotection by notch signaling.

Authors:  Nobunao Wakabayashi; John J Skoko; Dionysios V Chartoumpekis; Shoko Kimura; Stephen L Slocum; Kentaro Noda; Dushani L Palliyaguru; Masahiro Fujimuro; Patricia A Boley; Yugo Tanaka; Norihisa Shigemura; Shyam Biswal; Masayuki Yamamoto; Thomas W Kensler
Journal:  Mol Cell Biol       Date:  2013-12-02       Impact factor: 4.272

4.  Nrf2 represses the onset of type 1 diabetes in non-obese diabetic mice.

Authors:  Yoko Yagishita; Akira Uruno; Dionysios V Chartoumpekis; Thomas W Kensler; Masayuki Yamamoto
Journal:  J Endocrinol       Date:  2019-01-01       Impact factor: 4.286

5.  Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis.

Authors:  S C Cazanave; X Wang; H Zhou; M Rahmani; S Grant; D E Durrant; C D Klaassen; M Yamamoto; A J Sanyal
Journal:  Cell Death Differ       Date:  2014-04-25       Impact factor: 15.828

6.  Oral azathioprine leads to higher incorporation of 6-thioguanine in DNA of skin than liver: the protective role of the Keap1/Nrf2/ARE pathway.

Authors:  Sukirti Kalra; Ying Zhang; Elena V Knatko; Stewart Finlayson; Masayuki Yamamoto; Albena T Dinkova-Kostova
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-29

7.  Keap1 modulates the redox cycle and hepatocyte cell cycle in regenerating liver.

Authors:  Min Hu; Yuhong Zou; Shashank Manohar Nambiar; Joonyong Lee; Yan Yang; Guoli Dai
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 8.  Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.

Authors:  Shaohua Ma; Chorlada Paiboonrungruan; Tiansheng Yan; Kevin P Williams; M Ben Major; Xiaoxin Luke Chen
Journal:  Ann N Y Acad Sci       Date:  2018-05-11       Impact factor: 5.691

9.  Keap1 inhibition attenuates glomerulosclerosis.

Authors:  Yoichi Miyazaki; Akihiro Shimizu; Ira Pastan; Keiko Taguchi; Eriko Naganuma; Takafumi Suzuki; Tatsuo Hosoya; Takashi Yokoo; Akihiko Saito; Toshio Miyata; Masayuki Yamamoto; Taiji Matsusaka
Journal:  Nephrol Dial Transplant       Date:  2014-02-11       Impact factor: 5.992

10.  Absolute Amounts and Status of the Nrf2-Keap1-Cul3 Complex within Cells.

Authors:  Tatsuro Iso; Takafumi Suzuki; Liam Baird; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2016-11-28       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.